Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?
Chanu Rhee, Sanjat Kanjilal, Meghan A. Baker, et al.
Clinical Infectious Diseases (2020) Vol. 72, Iss. 8, pp. 1467-1474
Open Access | Times Cited: 220

Showing 26-50 of 220 citing articles:

Prospective study of 1308 nasopharyngeal swabs from 1033 patients using the LUMIPULSE SARS-CoV-2 antigen test: Comparison with RT-qPCR
Yosuke Hirotsu, Makoto Maejima, Masahiro Shibusawa, et al.
International Journal of Infectious Diseases (2021) Vol. 105, pp. 7-14
Open Access | Times Cited: 53
Organ recovery from deceased donors with prior COVID‐19: A case series
Nikole Neidlinger, Jeannina A. Smith, Anthony M. D’Alessandro, et al.
Transplant Infectious Disease (2020) Vol. 23, Iss. 2
Open Access | Times Cited: 51
COVID-19: A PCR-defined pandemic
Thirumalaisamy P. Velavan, Christian G. Meyer
International Journal of Infectious Diseases (2020) Vol. 103, pp. 278-279
Open Access | Times Cited: 51
Predictors of the prolonged recovery period in COVID-19 patients: a cross-sectional study
SeyedAhmad SeyedAlinaghi, Ladan Abbasian, Mohammad Solduzian, et al.
European journal of medical research (2021) Vol. 26, Iss. 1
Open Access | Times Cited: 50
Current state of diagnostic, screening and surveillance testing methods for COVID-19 from an analytical chemistry point of view
Julia Martı́n, Noelia Tena, Agustín G. Asuero
Microchemical Journal (2021) Vol. 167, pp. 106305-106305
Open Access | Times Cited: 46
The Effect of Corporate Social Responsibility and the Executive Compensation on Implicit Cost of Equity: Evidence from French ESG Data
Yamina Chouaibi, Matteo Rossi, Ghazi Zouari
Sustainability (2021) Vol. 13, Iss. 20, pp. 11510-11510
Open Access | Times Cited: 46
Association of Nirmatrelvir/Ritonavir Treatment on Upper Respiratory Severe Acute Respiratory Syndrome Coronavirus 2 Reverse Transcription-Polymerase Chain Reaction (SARS-Cov-2 RT-PCR) Negative Conversion Rates Among High-Risk Patients With Coronavirus Disease 2019 (COVID-19)
Hongyan Li, Menghan Gao, Hailong You, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e148-e154
Open Access | Times Cited: 27
Extreme differences in SARS-CoV-2 viral loads among respiratory specimen types during presumed pre-infectious and infectious periods
Alexander Viloria Winnett, Reid Akana, Natasha Shelby, et al.
PNAS Nexus (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 20
Reagent efficiency and analytical sensitivity optimization for a reliable SARS-CoV-2 pool-based testing strategy.
Patricio Miranda, Javiera Osorio, Márcia Silva, et al.
Heliyon (2025) Vol. 11, Iss. 1, pp. e41623-e41623
Open Access
Evaluation of two fluorescence immunoassays for the rapid detection of SARS-CoV-2 antigen—new tool to detect infective COVID-19 patients
Lorena Porte, Paulette Legarraga, Mirentxu Iruretagoyena, et al.
PeerJ (2021) Vol. 9, pp. e10801-e10801
Open Access | Times Cited: 38
SARS-CoV-2 Transmission Risk Among National Basketball Association Players, Staff, and Vendors Exposed to Individuals With Positive Test Results After COVID-19 Recovery During the 2020 Regular and Postseason
Christina Mack, John P. DiFiori, Caroline G. Tai, et al.
JAMA Internal Medicine (2021)
Open Access | Times Cited: 37
The role of chest imaging in the diagnosis, management, and monitoring of coronavirus disease 2019 (COVID-19)
Shohei Inui, Wataru Gonoi, Ryo Kurokawa, et al.
Insights into Imaging (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 32
Immune-Guided Therapy of COVID-19
Gianfranco Ferraccioli, Elisa Gremese, Delia Goletti, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 4, pp. 384-402
Open Access | Times Cited: 25
Photodynamic disinfection of SARS-CoV-2 clinical samples using a methylene blue formulation
Catarina S. Lobo, Paulo Rodrigues‐Santos, Dina Pereira, et al.
Photochemical & Photobiological Sciences (2022) Vol. 21, Iss. 6, pp. 1101-1109
Open Access | Times Cited: 24
Asymptomatic and pre-symptomatic infection in Coronavirus Disease 2019 pandemic
Yutong Wang, Ke Zheng, Wenjing Gao, et al.
Medical Review (2022) Vol. 2, Iss. 1, pp. 66-88
Open Access | Times Cited: 23
A quantitative systems pharmacology model of the pathophysiology and treatment of COVID-19 predicts optimal timing of pharmacological interventions
Rohit Rao, Cynthia J. Musante, Richard Allen
npj Systems Biology and Applications (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 12
Recommendations for sample pooling on the Cepheid GeneXpert® system using the Cepheid Xpert® Xpress SARS-CoV-2 assay
Michael G. Becker, Tracy Taylor, Sandra Kiazyk, et al.
PLoS ONE (2020) Vol. 15, Iss. 11, pp. e0241959-e0241959
Open Access | Times Cited: 34
Lung Protection vs. Infection Resolution: Interleukin 10 Suspected of Double-Dealing in COVID-19
Holger A. Lindner, Sonia Y. Velásquez, Manfred Thiel, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 31
Management of post-acute COVID-19 patients in geriatric rehabilitation: EuGMS guidance
Jolanda C. M. van Haastregt, Irma H. J. Everink, Jos M. G. A. Schols, et al.
European Geriatric Medicine (2021) Vol. 13, Iss. 1, pp. 291-304
Open Access | Times Cited: 31
Prospective Comparison of Saliva and Nasopharyngeal Swab Sampling for Mass Screening for COVID-19
Mathieu Nacher, Mayka Mergeay-Fabre, Denis Blanchet, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 28
Quantifying the Impact of Nasopharyngeal Specimen Quality on Severe Acute Respiratory Syndrome Coronavirus 2 Test Performance
Melissa Richard‐Greenblatt, Matthew J. Ziegler, Valerie Bromberg, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 6
Open Access | Times Cited: 27
Lower probability and shorter duration of infections after COVID-19 vaccine correlate with anti-SARS-CoV-2 circulating IgGs
Chiara Ronchini, Sara Gandini, Sebastiano Pasqualato, et al.
PLoS ONE (2022) Vol. 17, Iss. 1, pp. e0263014-e0263014
Open Access | Times Cited: 20
Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients
Verónica Rico, Mariana Fernández, Juan Carlos Hurtado, et al.
Infection (2022) Vol. 50, Iss. 5, pp. 1321-1328
Open Access | Times Cited: 20
Nationwide Harmonization Effort for Semi-Quantitative Reporting of SARS-CoV-2 PCR Test Results in Belgium
Lize Cuypers, Jannes Bode, Kurt Beuselinck, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1294-1294
Open Access | Times Cited: 20
Effect of vitamin D supplementation versus placebo on recovery delay among COVID-19 Tunisian patients: a randomized-controlled clinical trial
Héla Abroug, Amani Maatouk, Cyrine Bennasrallah, et al.
Trials (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 10

Scroll to top